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Like  most  mammalian  species,  humans  ex­
press several structurally distinct CD1 antigen­ 
presenting molecules. The conservation of large 
CD1 gene families among most mammals sug­
gests that each type of CD1 protein has distinct 
functions that confer selective advantage. Cellu­
lar studies of CD1 proteins increasingly explain 
how each CD1 protein differs from the others. 
CD1a, CD1b, CD1c, and CD1d have distinct 
antigen groove structures, patterns of expres­
sion in tissues, intracellular trafficking, and trig­
ger T cells expressing diverse TCRs (Kasmar   
et al., 2009). CD1d (group 2) diverges most 
clearly from CD1a, CD1b, and CD1c (group 1) 
with regard to protein sequence. Also, group 1 
and group 2 CD1 proteins show differing tran­
scriptional responses to pathogens, suggesting 
that they function at different stages of the 
immune response (Roura­Mir et al., 2005b). 
Collectively, these cellular studies suggest that 
group 1 and group 2 CD1 proteins likely have 
differing roles in immune responses.
The majority of known foreign ligands for 
group 1 CD1 molecules are mycobacterial in 
origin, including dideoxymycobactin, mycolic 
acid, lipoarabinomannan, glucose monomyco­
late (GMM), glycerol monomycolate, diacylated 
sulfoglycolipid,  phosphatidylinositol  mannoside, 
and mannosyl phosphomycoketide (De Libero 
and Mori, 2005). Human T cells proliferate or 
produce interferon­ in response to several types 
of  mycobacterial  lipid  antigens  presented  by 
group 1 CD1 proteins during latent or active tu­
berculosis infection, suggesting a function in host 
response to mycobacteria (Moody et al., 2000b; 
CORRESPONDENCE  
D. Branch Moody: 
bmoody@rics.bwh.harvard.edu
Abbreviation used: GMM, 
glucose monomycolate
CD1b tetramers bind  T cell receptors  
to identify a mycobacterial glycolipid-
reactive T cell repertoire in humans
Anne G. Kasmar,1 Ildiko van Rhijn,1,2 Tan-Yun Cheng,1 Marie Turner,3 
Chetan Seshadri,1 Andre Schiefner,4 Ravi C. Kalathur,4 John W. Annand,1 
Annemieke de Jong,1 John Shires,5 Luis Leon,1 Michael Brenner,1  
Ian A. Wilson,4 John D. Altman,5 and D. Branch Moody1
1Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115
2Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3508 TD Utrecht, Netherlands
3Tuberculosis Treatment Unit, Lemuel Shattuck Hospital, Jamaica Plain, MA 02130
4Department of Molecular Biology and Skaggs Institute for Chemical Biology, the Scripps Research Institute, La Jolla, CA 92037
5Emory Vaccine Center, Atlanta, GA 30329
Microbial lipids activate T cells by binding directly to CD1 and T cell receptors (TCRs) or by 
indirect effects on antigen-presenting cells involving induction of lipid autoantigens, CD1 
transcription, or cytokine release. To distinguish among direct and indirect mechanisms, we 
developed fluorescent human CD1b tetramers and measured T cell staining. CD1b tetramer 
staining of T cells requires glucose monomycolate (GMM) antigens, is specific for TCR 
structure, and is blocked by a recombinant clonotypic TCR comprised of TRAV17 and 
TRBV4-1, proving that CD1b–glycolipid complexes bind the TCR. GMM-loaded tetramers 
brightly stain a small subpopulation of blood-derived cells from humans infected with 
Mycobacterium tuberculosis, providing direct detection of a CD1b-reactive T cell reper-
toire. Polyclonal T cells from patients sorted with tetramers are activated by GMM antigens 
presented by CD1b. Whereas prior studies emphasized CD8+ and CD4CD8 CD1b-restricted 
clones, CD1b tetramer-based studies show that nearly all cells express the CD4 co-receptor. 
These findings prove a cognate mechanism whereby CD1b–glycolipid complexes bind to 
TCRs. CD1b tetramers detect a natural CD1b-restricted T cell repertoire ex vivo with un-
expected features, opening a new investigative path to study the human CD1 system.
© 2011 Kasmar et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first  six  months   
after the publication date (see http://www.rupress.org/terms). After six months it 
is available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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RESULTS AND DISCUSSION
Design of tetramerizable CD1b proteins
We produced a tetramerizable biotinylated CD1b monomer 
building  on  prior  designs  for  MHC  and  CD1d  tetramers 
(Altman et al., 1996; Gumperz et al., 2002). The extracellular 
domain of the human CD1b heavy chain was modified with 
a leucine zipper for binding to ­2 microglobulin and a Bir A 
sequence for biotinylation and complexed with streptavidin­
allophycocyanin (CD1b tetramer–APC). CD1b tetramers 
were loaded with glucose­6­monomycolate, a natural myco­
bacterial glycolipid antigen comprised of glucose in 6­linkage 
with mycolyl groups that exist in an alkane series (Fig. 1 a). 
Three GMM preparations with an average mycolyl unit of 
C32, C54, or C80 (C32 GMM, C54 GMM, and C80 GMM) 
were separately loaded onto CD1b tetramers and used to 
stain the GMM­reactive CD1b­restricted T cell line LDN5. 
Ulrichs et al., 2003; Gilleron et al., 2004; Layre et al., 2009; 
Montamat­Sicotte  et  al.,  2011).  However,  existing  experi­
mental models for study of group 1 CD1 function rely on 
activation assays that destroy the responding cells or focus on 
a limited number of in vitro–derived human T cell clones, 
which may not accurately reflect the in vivo phenotype. Con­
sequently, information about the precise frequencies, effector 
functions, and possible host­protective effects of group 1 
CD1­restricted T cells remain unknown. In contrast, the bi­
ological functions of CD1d and NKT cells have been broadly 
studied through mice deficient in CD1d or invariant  V14 or 
J18 T cell receptors, as well as CD1d tetramers (Benlagha   
et al., 2000; Matsuda et al., 2000; Karadimitris et al., 2001; 
Gumperz et al., 2002). Tetramers take advantage of multimer­
ization to generate high avidity fluorescent staining reagents 
that bind to individual clonotypic TCRs and selectively track 
antigen­specific T cells within much larger T cell populations 
(Altman et al., 1996). Tetramers can identify even rare anti­
gen­specific T cells (Moon et al., 2007) for functional analysis, 
and CD1d tetramers have allowed single­cell analysis of NKT 
cells during infection, autoimmunity, and cancer (Benlagha   
et al., 2000; Matsuda et al., 2000; Karadimitris et al., 2001; 
Gumperz et al., 2002; Lee et al., 2002; Jahng et al., 2004;   
Arrenberg et al., 2010). Germline deletion of group 1 pro­
teins is not currently feasible, so development of CD1 tetramers 
represents a promising method to study fresh antigen­specific 
T cells at the population level.
The  basic  principle  of  tetramer  staining  requires  that 
TCRs bind to the antigen­presenting molecule and that this 
physical interaction is mediated by a groove­bound cognate 
antigen that physically ligates CD1 to the TCR. For CD1d, 
lipids like synthetic ­galactosylceramides mediate the tri­
molecular complex of CD1d–antigen–TCR (Borg et al., 2007), 
so an analogous function of glycolipids in mediating TCR con­
tact with group 1 CD1 proteins is a leading model. However, 
recent  studies  have  emphasized  three  alternate  mechanisms 
whereby TCRs bind to CD1 or activate T cells but do not 
physically ligate CD1 and TCR. Lipopolysaccharide stimulates 
iNKT cell activation, not as a CD1d­bound lipid antigen but 
by triggering release of cytokines such as IL­12, which aug­
ments  CD1d–self­antigen–mediated  reactivity  (Brigl  et  al., 
2003,  2011).  Phosphatidylinositol  mannoside  might  activate   
T cells indirectly by up­regulating CD1b surface expression 
(Roura­Mir et al., 2005b), and bacterial lipids induce more 
stimulatory self­ligands for CD1 proteins (De Libero et al., 
2005; Paget et al., 2007). In each of the three scenarios, micro­
bial glycolipids and CD1 proteins are both needed to activate   
T cells through indirect mechanisms in which the foreign glyco­
lipid does not physically link CD1 to TCR. Therefore, tetra­
mers represent both a test of cognate antigen recognition by 
CD1b and a potential tool to physically isolate and characterize 
a foreign glycolipid­reactive T cell repertoire for the first time. 
In this paper, we show that human CD1b tetramers loaded 
with  a  mycobacterial  glycolipid  antigen,  GMM,  selectively 
bind to GMM­specific TCRs and directly isolate a natural 
CD1b and glycolipid­reactive T cell repertoire in humans.
Figure 1.  CD1b tetramers stain human  T cells. (a) Bacterial 
GMM is formed by glucose linked at the 6-position to a mycolyl unit that 
contains two chiral centers, which are in the R configuration at positions 
2 and 3 (2R, 3R). (b) Tetramerizable CD1b monomers were used in plate-
bound antigen presentation experiments to measure IL-2 release by the 
CD1b-restricted human T cell line LDN5 in response to C32 GMM loaded 
overnight at 37°C (mean + SEM). (c) CD1b was loaded with GMMs that 
are naturally formed with R configuration at C2 and C3 (R, R) or synthetic 
GMM prepared with an S configuration at C2 or C3 (2R,3S+2S,3R) and 
complexed to streptavidin-labeled APC (tetramer APC) and tested for 
staining LDN5 T cells. (d) CD1b tetramers were then loaded with GMMs of 
the indicated average chain length (C32, C54, or C80) and tested for 
staining LDN5. MFI is mean fluorescence intensity. Data are representative 
of three or more experiments.JEM Vol. 208, No. 9  1743
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lipids to fill in the remaining volume (Gadola et al., 2002; 
Batuwangala et al., 2004; Garcia­Alles et al., 2006).
CD1b tetramers bind the TCR- complex
The  cognate  model  predicts  that  the  surface  target  of   
tetramer binding is the heterodimer of rearranged TCR­ 
and ­ chains normally expressed on the LDN5 T cell clone, 
TRAV 17, and TRBV4­1. However, a physical interaction of 
TCRs with any group 1 CD1 protein has not been previ­
ously observed. In addition to any alternate surface ligands on 
T cells that are unknown and might bind to CD1b, NK re­
ceptors (Carbone et al., 2000) and immunoglobulin­like pro­
teins (ILT; Li et al., 2009) have been implicated in binding 
CD1 proteins. Therefore, we designed experiments to test the 
presence and specificity of a proposed interaction between 
CD1b with the clonotypic  TCR. CD1d tetramers made 
from the same type of construct failed to stain LDN5 but did 
stain  the  CD1d­restricted T  cell  clone  J3N.5,  implicating 
CD1 isoform–specific sequences in tetramer staining (Fig. S2). 
Preincubation with anti­CD1b or anti–TRBV4­1 blocked 
tetramer staining to background (Fig. 2 a and Fig. S3 a). These 
However,  initial  attempts  to  stain  were  unsuccessful,  even   
after confirming monomer purity, biotinylation, and multi­
merization of CD1b proteins, as well as successful staining of 
NKT cells with control CD1d tetramers (Fig. S1 a and Fig. S2). 
Tetramer  staining  requires  that  key  aspects  of  the  cellular 
loading mechanism, which is particularly stringent for CD1b, 
be replicated in vitro. Therefore, we tested the sufficiency of 
in vitro conditions for antigen loading. In particular, the ab­
sence  of  cellular  loading  cofactors  like  saposin  C  (Winau   
et al., 2004) and the lack of essential cellular processing might 
alter structures in ways that are required for binding. After 
optimizing the time, pH, and chain length of the antigen, we 
were able to see high­level T cell activation with a plate bound 
CD1b monomer loaded with a C32 GMM antigen. This   
result confirmed that cellular processing and loading cofac­
tors are not absolutely required and proved proper CD1b 
folding (Fig. 1 b).
CD1b tetramers bind to T cells
Using  optimized  conditions  for  loading  CD1b  with  C32 
GMM (Fig. S1 b), we observed CD1b tetramer staining of 
LDN5 (Fig. 1 c). Although CD1d tetramers bound to the 
synthetic  superagonist  ­galactosylceramide  brightly  stain 
CD1d­restricted T cells, self­antigens such as isogloboside 3 
or sulfatide result in absent or moderate tetramer staining 
(Jahng et al., 2004; Zhou et al., 2004; Arrenberg et al., 2010). 
Therefore, it is notable that GMM, a natural foreign antigen, 
gives bright staining, such that the mean fluorescence inten­
sity increases 10–100­fold after loading in optimized condi­
tions (Fig. 1 c). To determine whether staining is specific for 
the structure of the antigen or is a result of nonspecific hydro­
phobic interactions resulting from the presence of lipids, we 
exposed CD1b to natural and synthetic antigens that recapit­
ulate certain aspects of the C32 GMM structure. Whereas 
natural bacterial C32 GMM contains two chiral centers in 
the R conformation at the C2 and C3 positions of the mero­
mycolate chain GMM (2R, 3R), synthetic C32 GMM dia­
stereomers containing an S configuration at either position 
GMM (2R,3S + 2S,3R; Fig. 1 a) are nonantigenic (Moody   
et al., 2000a). Only C32 GMM (2R, 3R) mediated tetramer 
staining, indicating that chiral carbons, which determine the 
orientation of the glucose head group and ­hydroxyl unit 
relative to the TCR, are required for staining (Fig. 1 c).
In contrast, three preparations of natural bacterial GMMs 
containing a mean chain length of 32, 54, or 80 carbons and 
having 2R,3R configuration mediate bright staining (Fig. 1 d). 
Thus, C48 differences in overall lipid length can be tolerated, 
leading to high avidity binding. Whereas the length and con­
formation  of  the  alkane  chain  hidden  within  the  CD1d 
groove  can  significantly  influence  NKT  cell  activation   
(McCarthy  et  al.,  2007),  our  results  strongly  suggest  that 
CD1b­restricted TCR  binding  depends  critically  on  head 
group positioning but can tolerate very large differences in 
lipid chain length. These results support and extend prior 
work suggesting that C80 lipids fill the entire groove, whereas 
shorter lipids partially fill the groove, allowing smaller spacer 
Figure 2.  Tetramer staining proves a specific trimolecular inter-
action among CD1b, GMM, and the clonotypic TCR. (a) The LDN5 T cell 
clone was stained with unloaded CD1b tetramers or CD1b tetramers 
loaded with C32 GMM. Tetramers were preincubated with 10 µg/ml iso-
type control antibody or anti-CD1b antibody. (b) Soluble TCR- chains 
with hexahistidine tags and - chains with streptavidin tags were formed 
into soluble TCR dimers. (c) Loaded and unloaded tetramers were preincu-
bated with fivefold molar excess of soluble recombinant T cell receptors 
derived from CD1a-restricted (sCD8-2) or CD1b-restricted (sLDN5) T cell 
lines. Data are representative of three or more experiments.1744 CD1b tetramers detect human  T cells | Kasmar et al.
CD3 cells was minimized by two­color 
flow cytometry to detect CD3+tetramer+ 
cells (Fig. S3 d), setting the stage for clinical 
studies of human CD1b­restricted T cells.
Several population studies have detected 
increased interferon­ responses in tuberculosis patients, indi­
cating that lipid­reactive T cells likely expand during infec­
tion (Moody et al., 2000a; Ulrichs et al., 2003; Gilleron et al., 
2004; Layre et al., 2009; Montamat­Sicotte et al., 2011). How­
ever, group 1 CD1­restricted T cells have never been de­
tected directly ex vivo without stimulation. Tetramer detection 
is desirable because it rules out false positive results from cyto­
kine production by non­T cells, indirect stimulation of cells 
by lipid adjuvants, or activation of MHC­restricted cells by 
contaminating peptide antigens. Also, tetramer­based sorting 
allows live cell capture for diverse functional and phenotypic 
studies. Among four subjects with positive intradermal puri­
fied protein derivative tests, we observed a similar pattern: a 
small percentage of blood T cells (0.01%) stained brightly 
such that they were well separated from the pool of nonstain­
ing cells (Fig. 3 a). The absolute frequency of cells was de­
tected at similar rates among patients with latent (patients 1, 
2, and 4) and active tuberculosis (patient 3), but staining was 
not observed in three healthy controls (Fig. S4 c). The de­
tected frequency of T cells from individual patients was simi­
lar to one another and highly reproducible among experiments 
using blood from the same patient to assess different aspects of 
function and phenotype (Fig. 3, a and b; and Fig. 4, a and b).
To determine whether cells staining with CD1b–GMM 
complexes  functionally  recognized  CD1b  and  GMM,  we 
sorted CD3+ cells into tetramerhigh and tetramerlow popula­
tions (Fig. 3 b and Fig. S4 b). After recovery, total cells were 
tested in ­interferon ELISpot using K562 cells that do or do 
not express CD1b (de Jong et al., 2010). Only tetramerhigh 
cells produced interferon­ in response to GMM, and this re­
sponse required CD1b expression (Fig. 3 b). Thus, CD1b tetra­
mers directly identify populations of foreign glycolipid–reactive 
T cells in the blood of human tuberculosis patients that con­
stitute a natural sub­repertoire of human  T cells. A pre­
cursor frequency of 0.01% is similar to that of human NKT 
cells identified using CD1d tetramers (Gumperz et al., 2002).   
studies were consistent with interaction between CD1b and 
TCR  VB4­1, if binding of monoclonal antibodies directly inter­
fered with contact between TCR­ and the distal surface of 
CD1b. However, antibodies might have blocked staining in 
indirect ways involving sequestration of TCRs or CD1b pro­
teins. To definitively test the role of the distal domains of 
TRBV4­1  and TRAV17  in  physical  contact  with  CD1b­
GMM  complexes,  we  produced  soluble  leucine­zippered 
TCRs comprised of the distal domains of the TCR­ and ­ 
chains from LDN5 (sLDN5) and from CD8­2 (sCD8­2), a 
TRAV3, TRBV3­1  heterodimer  which  recognizes  CD1a 
(Fig. 2 b and Fig. S3 b). Preincubation with sCD8­2 TCR did 
not inhibit tetramer staining, but sLDN5 TCR reduced 
tetramer staining to background levels (Fig. 2 c). Thus, the 
clonotypic TCR is necessary for CD1b­GMM binding to 
cells, proving a cognate TCR interaction with the CD1b– 
antigen complex, which is TCR specific and necessary for 
cellular binding.
CD1b tetramers detect GMM-specific T cells  
during TB infection
Development of tetramers for study of patient blood in the 
setting  of  an  infectious  disease  requires  low  background 
among all types of cells present in PBMCs. To evaluate tetra­
mer specificity, we mixed LDN5 T cells with CD1d­restricted 
NKT cells and found that GMM­loaded CD1b tetramers   
selectively stained the TRVB4­1+ clonotypic T cells, with no 
detectable staining over background of T cells with another 
TCR  (Fig.  S3  c). Also,  titration  of  GMM­specific  LDN5   
T cells into fresh PBMC at known frequencies demonstrated 
that clonotypic T cells could be sensitively detected at the 
level of 0.01% of CD3+ cells. A discrete population of brightly 
staining cells was detected at frequencies near to their actual 
abundance when titrated into PBMC, so tetramers were not 
binding to T cells with diverse TCRs (Fig. S3 d). The poten­
tial problem of low but detectable background staining on 
Figure 3.  CD1b tetramers identify a myco-
bacterial glycolipid-reactive T cell repertoire in 
humans. (a) PBMCs of four subjects infected with 
Mycobacterium tuberculosis were stained with 
CD1b tetramers in addition to CD3 FITC, CD14 
PercP-Cy5.5, CD19 PerCP-Cy5.5, and violet viability 
dye and gated on live lymphocytes. (b) PBMCs from 
patient 1 were cultured overnight in 0.2 ng/ml  
IL-15 before FACS sorting. PBMCs from patient 2 
were expanded by stimulation with anti-CD3 in the 
presence of irradiated feeder cells and IL-2 before 
FACS sorting using CD3 FITC and CD1b tetramers. 
Equal numbers of cells were incubated with 20,000 
CD1b or empty vector–transfected K562 APCs with 
or without 5 µg/ml GMM (mean + SEM).JEM Vol. 208, No. 9  1745
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resulted from methods that depleted CD4 T cells in cultures 
to reduce MHC class II alloreactivity during cloning procedures. 
This was a key intervention that allowed the discovery of CD1­
restricted T cells, but unbiased study of the CD1b and GMM 
repertoire now suggests that the CD4+ population dominates.
Identification of the CD1b and GMM reactive repertoire 
as TCR­+CD4+  provides  basic  information  about  the 
CD1b­restricted T cell subset, which raises new questions 
about potential infection of these cells by HIV as well as a 
possible role of CD4 in development and effector function of 
this T cell subset. Furthermore, these results illustrate how any 
phenotypic question can be approached without confounders 
relating to in vitro growth or contaminating peptide antigens. 
Whereas NKT cells can be studied in CD1d­ or J18­altered 
mice with human or mouse tetramers, there is no widely used 
small animal model for CD1b. Therefore, CD1b tetramers 
open a broad window for detailed study of the immuno­
biology of these cells. In contrast to highly polymorphic MHC 
proteins, which require haplotype matching for donors, the 
low rates of CD1 polymorphism in human populations allow 
one CD1b sequence in tetramer form to be readily applied   
to almost any human donor in ways that facilitate popula­
tion studies. Prior clinical studies indicate that group 1 CD1 
T cell responses are frequent in human tuberculosis patients 
(Moody et al., 2000a; Ulrichs et al., 2003; Gilleron et al., 2004; 
Layre et al., 2009; Montamat­Sicotte et al., 2011), so CD1 
tetramers might be developed as a means of immunodiagnosis. 
Future studies will take advantage of this technology to deter­
mine whether the CD4+ T cell populations described in this 
Despite limited numbers in the peripheral circulation, lipid­
specific T cells have been proposed to act locally near the site 
as helper cells whose function is magnified by downstream 
responses of dendritic cells or other T cells (Vincent et al., 
2002; Roura­Mir et al., 2005a,b). Sorting of blood­derived 
cells with CD1b tetramers can address core issues of CD1b­
restricted T cell phenotype and function previously addressed 
in T cell clones which can now be studied ex vivo.
Distinct features of the CD1b-GMM repertoire
The first and subsequent studies of group 1 CD1­restricted 
clones show expression of either  or  TCRs (Porcelli   
et al., 1992; Spada et al., 2000) in combination with CD4, 
CD8, or neither co­receptor. We found that CD1b tetramerhigh 
T cells uniformly stain with antibody against invariant com­
ponents of  TCRs in all four patients tested (Fig. 4 a). 
CD4 and CD8 represent key subset markers for NKT cell 
and MHC­restricted T cells because they strongly influence 
thymic selection and, thereby, determine effector functions. 
CD1b­restricted T cell clones can express CD4 or CD8 or 
neither co­receptor (Porcelli et al., 1992; Moody et al., 1997; 
Stenger et al., 1998), but any general view of co­receptor   
expression is limited by the small number of clones studied and 
the possibility of selective outgrowth in vitro. Given the large 
number of CD4CD8 and CD8+ clones isolated in early 
work on CD1b, it was unexpected to observe that CD4 single­ 
positive cells dominate the population of tetramer+ T cell 
populations cells in all four patients studied (Fig. 4 b). The 
absence of CD4 positivity in early clone­based studies likely 
Figure 4.  CD1b-restricted T cell populations express the  TCR and CD4. PBMCs from four subjects infected with Mycobacterium tuberculosis 
were subjected to multicolor FACS analysis. Cells were stained with CD3, violet viability dye, CD14 and CD19-PercP-Cy5.5, loaded CD1b tetramers, and 
anti–TCR- (a) and CD4 (b).1746 CD1b tetramers detect human  T cells | Kasmar et al.
CD1b tetramer staining of clones. CD1b tetramers were validated by stain­
ing the clone LDN5 (Moody et al., 1997). In brief, 2 × 105 T cells were treated 
with human AB serum for 10 min, washed, and then suspended in FACS buffer 
(PBS with 2% fetal calf serum; Gemini) and stained with 1 µg of fluorescently   
labeled CD1b tetramer for 60 min at room temperature in the dark. Cells were 
acquired on a FACSCanto flow cytometer (BD) and analyzed using FlowJo 
(Tree Star) software with doublet exclusion based on forward and side scatter in 
the presence or absence of anti­CD1b or recombinant TCRs.
Tetramer staining of human PBMC. After informed consent, 50 ml of 
blood were collected from healthy controls, asymptomatic tuberculin­positive 
subjects with no clinical or radiographical evidence of active tuberculosis, 
and active tuberculosis patients overseen by the institutional review boards of 
the Lemuel Shattuck Hospital (00000786) and Partners Healthcare (2002­ 
P­000061) and the Harvard Committee on Microbiologic Safety (08–184). 
PBMCs were separated by Ficoll density gradient centrifugation. After thaw­
ing, one million PBMCs were treated with human AB serum and stained 
with 1 µg tetramer for 40 min at room temperature in the dark, after which 
they were stained with violet fluorescent reactive dye (Invitrogen) to exclude 
dead cells. Cells were stained with monoclonal antibodies including CD3 
(BD), CD14 (BD), and CD19 (eBioscience) for an additional 20 min and 
then fixed in 2% formaldehyde before FACS analysis. Cells from patient 1 
were stained in 12 experiments; cells from patients 2, 3, and 4 were each 
stained four times. For functional assays, unfixed tetramer­positive cells were 
sorted using a FACSAria flow cytometer and tested for antigen specificity 
using untransfected or CD1b­transfected K562 cells as antigen presenting 
cells in ELISpot assays (de Jong et al., 2010). Tetramer­positive cells were 
stained with TCR­ FITC (BD) or CD4­PE (BD).
Online supplemental material. Fig. S1 shows optimization of tetramer 
staining of the T cell clone LDN5. Fig. S2 shows a comparison of CD1b 
and CD1d tetramer staining. Fig. S3 shows tetramers staining clonotypic   
T cell receptors. Fig. S4 shows FACS gating strategies and tetramer staining 
of healthy controls. Online supplemental material is available at http://www 
.jem.org/cgi/content/full/jem.20110665/DC1.
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paper may be expanded in the blood and tissues of tuberculo­
sis patients and express effector functions that contribute to 
control of mycobacterial infection, like interferon­, TNF­, 
and granulysin (Stenger et al., 1998), or instead have un­
expected roles in immunosuppression or immunopathology.
MATERIALS AND METHODS
Generation  of  soluble  CD1b  proteins.  Soluble  biotinylated  CD1b 
monomers were produced in lentivirus­transduced HEK293 T cells by the 
National  Institutes  of  Health Tetramer  Core  Facility  (Emory  University,   
Atlanta,  GA)  and  tetramerized  with  fluorescently  labeled  streptavidin.  In 
brief, human ­2­microglobulin and the extracellular domain of CD1b were 
cloned into the expression vector pCMJJ4 (gift from J. Jacob, Emory Univer­
sity, Atlanta, GA). Lentiviral particles were made in a second generation pack­
aging system (Naldini et al., 1996). The light and heavy chains are expressed 
under control of the CMV promoter and are separated by the 2A­TaV pep­
tide to generate two separate proteins from a single mRNA. The chains are 
followed by a C­terminal acidic or basic leucine zipper which stabilizes the 
complex and is used for affinity purification using the 2H11 monoclonal   
antibody  (E.  Reinherz,  Harvard,  Boston,  MA).  Purified  monomers  were   
enzymatically biotinylated at the BirA site at the C terminus of the heavy chain. 
Monomer purity and composition were confirmed by PAGE, and biotinyla­
tion was confirmed by streptavidin bead pulldown assay. Functional activity was 
assayed by affixing biotinylated monomers at final concentration of 5 µg/ml onto 
96­well streptavidin plates (Thermo Fisher Scientific) in PBS, pH 7.4, for 24 h   
at 37°C. Lipid antigens were sonicated in PBS for 2 min, added to the wells,   
and incubated for 24 h at 37°C before washing three times with 200 µl/well 
sterile PBS. 105 LDN5 cells were added in a total volume of 200 µl  T cell medium   
per well (RPMI). The plate was incubated for 24 h at 37°C after which culture   
supernatants were collected for HT2 bioassay.
Generation of soluble clonotypic TCR- complexes. The cDNAs of 
the  and  chains of TCR (LDN5 and CD8.2) were cloned into the baculo­
virus transfer vector pAcUW51 (BD). Honey Bee Melittin and envelope 
glycoprotein gp67 were used as signal peptides to optimize secretion of the 
 and  chains. The C terminus of the  chain has a thrombin cleavage   
site followed by an acidic zipper and hexahistidine tag. The  chain also   
has a thrombin cleavage site followed by a basic zipper and Strep­tag II 
(WSHPQFEK). The TCRs were expressed using the baculovirus cotransfec­
tion method and the protein was secreted by SF9 insect cells. The secreted 
TCR from the supernatant was purified using Nickel beads (QIAGEN), and 
a Strep­Tactin column (IBA), followed by gel­filtration chromatography. 
The pooled protein was concentrated to 1 mg/ml in 20 mM Tris­HCl and 
100 mM NaCl, pH 8.0, confirmed for purity by gel electrophoresis, and 
stored at 80°C in small aliquots.
Loading CD1b monomers with GMM. GMM with differing average 
chain lengths produced by Rhodococcus equi (C32), Nocardia farcinica (C54), or 
Mycobacterium phlei (C80) was isolated as previously described (Moody et al., 
2002). Antigen identity and purity were confirmed by biochemical analysis 
including thin layer chromatography and electrospray ionization mass spec­
trometry in the positive mode (LXQ Linear Ion Trap Mass Spectrometer; 
Thermo Fisher Scientific). Loading conditions were guided by results from   
T cell activation by monomeric proteins and optimized by staining T cells   
after loading under conditions ranging in pH (5–7.4), temperature (20–37°C), 
concentration  (10–100­fold  excess  antigen),  and  time  (2–24  h).  Optimal 
staining was seen with GMM sonicated into 50 mM sodium citrate at pH 5.0 
for 2 min, added at 40­fold molar excess to CD1b monomers, and incubated 
in a 37°C water bath for 2 h with vortexing every 15 min, followed by incu­
bation at room temperature for an additional 22 h before neutralization to 
pH 7.4 with 10 µl TRIS, pH 9. The duration of antigen loading and the   
purity of antigen preparations were critical for obtaining bright staining of   
T cells. After loading, CD1b monomers were multimerized using fluores­
cently labeled streptavidin (Invitrogen) at a 5:1 molar ratio.JEM Vol. 208, No. 9  1747
Brief Definitive Report
Brigl, M., L. Bry, S.C. Kent, J.E. Gumperz, and M.B. Brenner. 2003. Mechanism 
of CD1d­restricted natural killer T cell activation during microbial in­
fection. Nat. Immunol. 4:1230–1237. doi:10.1038/ni1002
Brigl, M., R.V.V. Tatituri, G.F.M. Watts, V. Bhowruth, E.A. Leadbetter, N. 
Barton, N.R. Cohen, F.­F. Hsu, G.S. Besra, and M.B. Brenner. 2011. 
Innate and cytokine­driven signals, rather than microbial antigens, domi­
nate in natural killer T cell activation during microbial infection. J. Exp. 
Med. 208:1163–1177. doi:10.1084/jem.20102555
Carbone, E., G. Terrazzano, A. Melián, D. Zanzi, L. Moretta, S. Porcelli, K. 
Kärre, and S. Zappacosta. 2000. Inhibition of human NK cell­mediated 
killing by CD1 molecules. J. Immunol. 164:6130–6137.
de Jong, A.,  V. Peña­Cruz, T.­Y. Cheng, R.A. Clark, I.  Van Rhijn, and D.B. Moody. 
2010. CD1a­autoreactive T cells are a normal component of the human  
T cell repertoire. Nat. Immunol. 11:1102–1109. doi:10.1038/ni.1956
De Libero, G., and L. Mori. 2005. Recognition of lipid antigens by T cells. 
Nat. Rev. Immunol. 5:485–496. doi:10.1038/nri1631
De Libero, G., A.P. Moran, H.J. Gober, E. Rossy, A. Shamshiev, O. Chelnokova, 
Z. Mazorra, S.  Vendetti, A. Sacchi, M.M. Prendergast, et al. 2005. Bacterial 
infections  promote T  cell  recognition  of  self­glycolipids.  Immunity. 
22:763–772. doi:10.1016/j.immuni.2005.04.013
Gadola, S.D., N.R. Zaccai, K. Harlos, D. Shepherd, J.C. Castro­Palomino, G. 
Ritter, R.R. Schmidt, E.Y. Jones, and V. Cerundolo. 2002. Structure of 
human CD1b with bound ligands at 2.3 A, a maze for alkyl chains. Nat. 
Immunol. 3:721–726. doi:10.1038/ni821
Garcia­Alles,  L.F.,  K. Versluis,  L.  Maveyraud, A.T. Vallina,  S.  Sansano,  N.F.  
Bello,  H.J.  Gober, V.  Guillet,  H.  de  la  Salle,  G.  Puzo,  et  al.  2006. 
Endogenous phosphatidylcholine and a long spacer ligand stabilize the 
lipid­binding groove of CD1b. EMBO J. 25:3684–3692. doi:10.1038/ 
sj.emboj.7601244
Gilleron,  M.,  S.  Stenger,  Z.  Mazorra,  F. Wittke,  S.  Mariotti,  G.  Böhmer,   
J. Prandi, L. Mori, G. Puzo, and G. De Libero. 2004. Diacylated sulfo­
glycolipids are novel mycobacterial antigens stimulating CD1­restricted 
T  cells  during  infection  with  Mycobacterium  tuberculosis.  J.  Exp.  Med. 
199:649–659. doi:10.1084/jem.20031097
Gumperz, J.E., S. Miyake, T.  Yamamura, and M.B. Brenner. 2002. Functionally 
distinct  subsets  of  CD1d­restricted  natural  killer T  cells  revealed  by 
CD1d tetramer staining. J. Exp. Med. 195:625–636. doi:10.1084/jem 
.20011786
Jahng, A., I. Maricic, C. Aguilera, S. Cardell, R.C. Halder, and V. Kumar. 2004. 
Prevention of autoimmunity by targeting a distinct, noninvariant CD1d­
reactive T cell population reactive to sulfatide. J. Exp. Med. 199:947–957. 
doi:10.1084/jem.20031389
Karadimitris,  A.,  S.  Gadola,  M.  Altamirano,  D.  Brown,  A.  Woolfson,  P. 
Klenerman, J.L. Chen, Y. Koezuka, I.A. Roberts, D.A. Price, et al. 2001. 
Human  CD1d­glycolipid  tetramers  generated  by  in  vitro  oxidative 
refolding  chromatography.  Proc.  Natl. Acad.  Sci.  USA.  98:3294–3298. 
doi:10.1073/pnas.051604498
Kasmar, A., I. Van Rhijn, and D.B. Moody. 2009. The evolved functions of 
CD1 during infection. Curr. Opin. Immunol. 21:397–403. doi:10.1016/ 
j.coi.2009.05.022
Layre, E., A. Collmann, M. Bastian, S. Mariotti, J. Czaplicki, J. Prandi, L. Mori, S. 
Stenger, G. De Libero, G. Puzo, and M. Gilleron. 2009. Mycolic acids con­
stitute a scaffold for mycobacterial lipid antigens stimulating CD1­restricted   
T cells. Chem. Biol. 16:82–92. doi:10.1016/j.chembiol.2008.11.008
Lee, P.T., K. Benlagha, L. Teyton, and A. Bendelac. 2002. Distinct functional 
lineages of human  V(alpha)24 natural killer T cells. J. Exp. Med. 195:637–
641. doi:10.1084/jem.20011908
Li, D., L. Wang, L.  Yu, E.C. Freundt, B. Jin, G.R. Screaton, and X.N. Xu. 2009. 
Ig­like transcript 4 inhibits lipid antigen presentation through direct 
CD1d interaction. J. Immunol. 182:1033–1040.
Matsuda, J.L., O.V. Naidenko, L. Gapin, T. Nakayama, M. Taniguchi, C.R. 
Wang, Y. Koezuka, and M. Kronenberg. 2000. Tracking the response of 
natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. 
Med. 192:741–754. doi:10.1084/jem.192.5.741
McCarthy, C., D. Shepherd, S. Fleire, V.S. Stronge, M. Koch, P.A. Illarionov, 
G. Bossi, M. Salio, G. Denkberg, F. Reddington, et al. 2007. The length 
of lipids bound to human CD1d molecules modulates the affinity of 
NKT cell TCR and the threshold of NKT cell activation. J. Exp. Med. 
204:1131–1144. doi:10.1084/jem.20062342
Montamat­Sicotte, D.J., K.A. Millington, C.R. Willcox, S. Hingley­Wilson,   
S. Hackforth, J. Innes, O.M. Kon, D.A. Lammas, D.E. Minnikin, G.S. Besra, 
et al. 2011. A mycolic acid­specific CD1­restricted T cell population 
contributes to acute and memory immune responses in human tubercu­
losis infection. J. Clin. Invest. 121:2493–2503. doi:10.1172/JCI46216
Moody, D.B., B.B. Reinhold, M.R. Guy, E.M. Beckman, D.E. Frederique, S.T. 
Furlong, S.  Ye,  V.N. Reinhold, P.A. Sieling, R.L. Modlin, et al. 1997. Struc­
tural requirements for glycolipid antigen recognition by CD1b­restricted 
T cells. Science. 278:283–286. doi:10.1126/science.278.5336.283
Moody, D.B., M.R. Guy, E. Grant, T.­Y. Cheng, M.B. Brenner, G.S. Besra, and 
S.A. Porcelli. 2000a. CD1b­mediated T cell recognition of a glycolipid 
antigen generated from mycobacterial lipid and host carbohydrate dur­
ing infection. J. Exp. Med. 192:965–976. doi:10.1084/jem.192.7.965
Moody, D.B., T. Ulrichs, W. Mühlecker, D.C. Young, S.S. Gurcha, E. Grant, 
J.­P. Rosat, M.B. Brenner, C.E. Costello, G.S. Besra, and S.A. Porcelli. 
2000b. CD1c­mediated T­cell recognition of isoprenoid glycolipids in 
Mycobacterium tuberculosis infection. Nature. 404:884–888. doi:10.1038/ 
35009119
Moody, D.B., V. Briken, T.Y. Cheng, C. Roura­Mir, M.R. Guy, D.H. Geho, 
M.L. Tykocinski, G.S. Besra, and S.A. Porcelli. 2002. Lipid length controls 
antigen entry into endosomal and nonendosomal pathways for CD1b 
presentation. Nat. Immunol. 3:435–442.
Moon, J.J., H.H. Chu, M. Pepper, S.J. McSorley, S.C. Jameson, R.M. Kedl, 
and M.K. Jenkins. 2007. Naive CD4(+) T cell frequency varies for dif­
ferent epitopes and predicts repertoire diversity and response magnitude. 
Immunity. 27:203–213. doi:10.1016/j.immuni.2007.07.007
Naldini,  L.,  U.  Blömer,  P.  Gallay,  D.  Ory,  R.  Mulligan,  F.H.  Gage,  I.M. 
Verma, and D. Trono. 1996. In vivo gene delivery and stable transduc­
tion of nondividing cells by a lentiviral vector. Science. 272:263–267. 
doi:10.1126/science.272.5259.263
Paget, C., T. Mallevaey, A.O. Speak, D. Torres, J. Fontaine, K.C.F. Sheehan, M. 
Capron, B. Ryffel, C. Faveeuw, M. Leite de Moraes, et al. 2007. Activation 
of invariant NKT cells by toll­like receptor 9­stimulated dendritic cells 
requires  type  I  interferon  and  charged  glycosphingolipids.  Immunity. 
27:597–609. doi:10.1016/j.immuni.2007.08.017
Porcelli, S., C.T. Morita, and M.B. Brenner. 1992. CD1b restricts the re­
sponse of human CD4­8­ T lymphocytes to a microbial antigen. Nature. 
360:593–597. doi:10.1038/360593a0
Roura­Mir,  C.,  M.  Catálfamo, T.­Y.  Cheng,  E.  Marqusee,  G.S.  Besra,  D. 
Jaraquemada, and D.B. Moody. 2005a. CD1a and CD1c activate intra­
thyroidal T  cells  during  Graves’  disease  and  Hashimoto’s  thyroiditis.   
J. Immunol. 174:3773–3780.
Roura­Mir, C., L. Wang, T.­Y. Cheng, I. Matsunaga, C.C. Dascher, S.L. Peng, 
M.J. Fenton, C. Kirschning, and D.B. Moody. 2005b. Mycobacterium   
tuberculosis regulates CD1 antigen presentation pathways through TLR­2. 
J. Immunol. 175:1758–1766.
Spada, F.M., E.P. Grant, P.J. Peters, M. Sugita, A. Melián, D.S. Leslie, H.K. 
Lee, E. van Donselaar, D.A. Hanson, A.M. Krensky, et al. 2000. Self­ 
recognition of CD1 by / T cells: implications for innate immunity.   
J. Exp. Med. 191:937–948. doi:10.1084/jem.191.6.937
Stenger, S., D.A. Hanson, R. Teitelbaum, P. Dewan, K.R. Niazi, C.J. Froelich, 
T. Ganz, S. Thoma­Uszynski, A. Melián, C. Bogdan, et al. 1998. An anti­
microbial activity of cytolytic T cells mediated by granulysin. Science. 
282:121–125. doi:10.1126/science.282.5386.121
Ulrichs, T., D.B. Moody, E. Grant, S.H. Kaufmann, and S.A. Porcelli. 2003. T­cell 
responses to CD1­presented lipid antigens in humans with Mycobacterium 
tuberculosis  infection.  Infect.  Immun.  71:3076–3087.  doi:10.1128/IAI.71 
.6.3076­3087.2003
Vincent, M.S., D.S. Leslie, J.E. Gumperz, X. Xiong, E.P. Grant, and M.B. Brenner. 
2002. CD1­dependent dendritic cell instruction. Nat. Immunol. 3:1163–
1168. doi:10.1038/ni851
Winau, F.,  V. Schwierzeck, R. Hurwitz, N. Remmel, P.A. Sieling, R.L. Modlin, 
S.A. Porcelli,  V. Brinkmann, M. Sugita, K. Sandhoff, et al. 2004. Saposin C 
is required for lipid presentation by human CD1b. Nat. Immunol. 5:169–
174. doi:10.1038/ni1035
Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv, K. 
Hudspeth, Y.P. Wu, T. Yamashita, et al. 2004. Lysosomal glycosphingo­
lipid recognition by NKT cells. Science. 306:1786–1789. doi:10.1126/ 
science.1103440